PJ Media: The EU's Banking Ruse to Create a United States of Europe

By SIMON CONSTABLE

Is the EU trying to pull a ‘fast one’ on its citizens? Maybe so.

Some recent efforts aimed at saving Europe’s banks from another financial crisis may be a Trojan horse aimed at abolishing the nation states of the European Union.

Of course, the EU isn't portraying its efforts that way. Instead, eurocrats (a.k.a. European bureaucrats) are disguising their work as an effort to save the public from a repeat of the 2008-09 taxpayer-funded banking bailouts. Read more here.

Joe Piscopo Show: Talking Markets

By SIMON CONSTABLE

Forbes: Bitcoin Trips at Its First Major Test

By SIMON CONSTABLE

It looks like Bitcoin didn't do that well in its first major test as a substitute for gold.

While the S&P 500 and the Dow Jones Industrial Average plummeted Monday, so did the price of bitcoin, which is the best known of all the so-called Crypto-currencies. Gold prices remained remarkably steady. Read more here.

John Batchelor Show: The missing volatility is back.

By SIMON CONSTABLE

WSJ: The Benefits of Buying Both the Best- and Worst-Performing Funds

By SIMON CONSTABLE

Should you invest in last year’s underperformers or continue with last year’s winners? The answer is yes, according to a recent analysis. Read more here.

WSJ: What Is Hot Money?

By SIMON CONSTABLE

Investors in some emerging markets may hear warnings about hot money. So, what is it and why does it matter? Read more here.

Photo by Giorgio Trovato on Unsplash

P.J. Media: The Government’s Inflation Data Caught 'Percentile Dysfunction'

By SIMON CONSTABLE

As if we didn’t already know something was wrong with the government’s inflation data, now up pops what looks like a confession. It’s part of a broader issue with government metrics that one economist dubs “percentile dysfunction.”

New research shows there’s a problem in how the prescription drug portion of the consumer price index gets calculated. Another, perhaps more realistic, index of drug prices far outgrew the CPI's drug metric over a recent five-year sample period, with one part of the alternative metric increasing 59 percent more. Read more here.